CNS vs NEA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CNS exhibits a stable financial foundation with a Piotroski F-Score of 5/9 and very low debt (D/E 0.22), but it is fundamentally overvalued. The current price of $67.71 trades at a significant premium to both the Graham Number ($27.35) and the growth-based Intrinsic Value ($50.59). This valuation gap is compounded by a bearish technical trend (0/100), insider selling, and a dangerously high dividend payout ratio of 83.77%. Recent earnings performance is lackluster, with only one beat in the last four quarters.
NEA exhibits strong operational health with a Piotroski F-Score of 7/9, yet it faces significant valuation and sustainability headwinds. The current price of $11.47 trades at a substantial premium to both the Graham Number ($8.62) and Intrinsic Value ($8.26). While the Price/Book ratio of 0.97 suggests fair value relative to assets, the unsustainable payout ratio of 307.50% indicates that dividends are likely being funded by capital or leverage rather than earnings. Technical trends are currently bearish, offsetting the fund's strong financial health score.
Compare Another Pair
Related Comparisons
CNS vs NEA: Head-to-Head Comparison
This page compares Cohen & Steers, Inc. (CNS) and Nuveen AMT-Free Quality Municipal Income Fund (NEA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.